Aller au contenu principal
Accès ouvert déclaré 2026 article

Biopsy-proven myocarditis: peripheral immunophenotypes correlate with histology, etiology, immunosuppressive therapy

0Citations signalées, ce qui n’est pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : it. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Myocarditis is an inflammatory disease of the myocardium with infectious or immune-mediated/autoimmune etiology; etiology diagnosis relays on endomyocardial biopsy (EMB). High titre serum anti-heart autoantibodies (AHA) define severe autoimmune forms. In autoimmune myocarditis immunosuppression (IS) may be required to prevent progression to dilated cardiomyopathy, heart transplant or death, but it is not always effective. This study aimed to identify non-invasive cellular biomarkers of etiology and response to IS in biopsy-proven myocarditis peripheral blood. Fifty-eight EMB-proven myocarditis patients out of IS were enrolled and compared with 9 healthy controls and 20 EMB-proven myocarditis on IS. Cells distribution was evaluated by flow cytometry; results were related to clinical, EMB and AHA findings. Compared to healthy controls, plasmacytoid dendritic cells percentage was reduced in autoimmune (p=0.017), in lymphocytic (p=0.012) myocarditis patients, in those without extra-cardiac autoimmune diseases (AD, p=0.01), and in myocarditis not on IS (p=0.003). Viral myocarditis had higher CD62L+/CD56+ NK cells percentage (p=0.001) and CCR2 over-expression in intermediate monocytes when compared with autoimmune myocarditis (p=0.013). Autoimmune myocarditis was characterized by higher Th1/Th2 (p=0.004) and Th17/Treg ratio (p=0.008), Th1 (p=0.028) and Th17 lymphocytes (p=0.017) percentage vs. healthy controls. A reduction of Treg cells percentage was specific for autoimmune lymphocytic (p=0.047 vs healthy controls), for AHA-positive myocarditis (p=0.03 vs healthy controls) and for myocarditis unresponsive to IS (p=0.036). Biopsy-proven myocarditis patients showed distinct peripheral immunophenotypes of either innate or adaptive immune cells according to different histology, etiology and response to IS, unveiling potential novel non-invasive etiological biomarkers for myocarditis. Graphic Abstract: Methods and key results are reported in the central illustration. CD: cluster of differentiation, CCR2: C-C motif chemokine receptor 2, IS: immunosuppression, NK: natural killer, pDC: plasmacytoid dendritic cell, Th: T helper, vs: versus. • Biopsy-proven (BP) myocarditis had peculiar peripheral immunophenotypes. • Patients were stratified for histology, etiology and response to immunosuppression. • Immune cells distribution varied among the different BP-myocarditis forms. • Peripheral blood immunophenotype may contribute to BP-myocarditis prognostic stratification.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Biopsy-proven myocarditis: peripheral immunophenotypes correlate with histology, etiology, immunosuppressive therapy
Date Crossref
01/06/2026
Éditeur
Elsevier BV
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • University of Padua pays non établi dans la notice
    Université ou école supérieure
  • University of Padova Department of Cardiac pays non établi dans la notice
    Université ou école supérieure

University of Padua et Department of Cardiac — University of Padova.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Viral Infections and Immunology ResearchAnimal Virus Infections StudiesEosinophilic Disorders and Syndromes

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.